Effect of UBR5 on the tumor microenvironment and its related mechanisms in cancer*

Author:

Wang Guangyu1,Yin Sutong2,Afrifa Justice3,Rong Guihong4,Jiang Shaofeng5,Guo Haonan4,Hou Xianliang1

Affiliation:

1. Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China

2. Reproductive Medical Center, No. 924 Hospital of Chinese People’s Liberation Army, Guilin 541001, China

3. Department of Medical Laboratory Science, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana

4. Department of Clinical Laboratory, The Affiliated Hospital of Guilin Medical University, Guilin 541001, China

5. Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541199, China

Abstract

Abstract Objective UBR5, recently identified as a potential target for cancer therapeutics, is overexpressed in multiple malignant tumors. In addition, it is closely associated with the growth, prognosis, metastasis, and treatment response of multiple types of cancer. Although emerging evidence supports the relationship between UBR5 and cancer, there are limited cancer analyses available. Methods In this study, online databases (TIMER2, GEPIA2, UALCAN, c-BioPortal, STRING) were employed to comprehensively explore expression levels and prognostic values of the UBR5 gene in cancer, using bioinformatic methods. Results We found that various characteristics of the UBR5 gene such as gene expression, survival value, genetic mutation, protein phosphorylation, immune infiltration, and pathway activities in the normal tissue were remarkably different from those in the primary tumor. Furthermore, “protein processing in spliceosome” and “ubiquitin mediated proteolysis” have provided evidence for their potential involvement in the development of cancer. Conclusion Our findings may provide insights for the selection of novel immunotherapeutic targets and prognostic biomarkers for cancer.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference38 articles.

1. New advances in the treatment for small cell lung cancer.;Cui;Chin J Lung Cancer (Chinese),,2019

2. Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.;Ge;BMC Cancer,,2019

3. Advances in Raman spectroscopy for nasopharyngeal carcinoma tissue.;Xu;Spectrosc Spectr Anal,,2016

4. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response.;Henderson;J Biol Chem,,2002

5. UBR5 interacts with the replication fork and protects DNA replication from DNA polymerase η toxicity.;Cipolla;Nucleic Acids Res,,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3